Spinal Muscular Atrophy (SMA) Treatment Market Report

Global and China Spinal Muscular Atrophy (SMA) Treatment Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 12, 2022
  • PAGES：139
  • REPORT CODE：GMM1458377
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration.

    North America dominates the global market for SMA treatment due to the high prevalence of SMA and increased adoption of SMA treatment options in the region.

    This report elaborates on the current development of the Spinal Muscular Atrophy (SMA) Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Biogen Idec

    • Ionis Pharmaceuticals

    • Scholor Rock

    • Novartis

    • Roche

    • Pfizer

    • Isis Pharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Type I Spinal Muscular Atrophy (SMA)

    • Type II Spinal Muscular Atrophy (SMA)

    • Type III Spinal Muscular Atrophy (SMA)

    Application:

    • Hospitals

    • Ambulatory Surgical Centers

    • Diagnostic Centers

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Spinal Muscular Atrophy (SMA) Treatment Industry Overview

      • 1.1.1 Spinal Muscular Atrophy (SMA) Treatment Market Scope and Market Segments

      • 1.1.2 Spinal Muscular Atrophy (SMA) Treatment Industry Characteristics

      • 1.1.3 Global and China Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Spinal Muscular Atrophy (SMA) Treatment Production Value and Growth Rate (2017-2028)

    • 1.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Type I Spinal Muscular Atrophy (SMA)

      • 1.2.2 Type II Spinal Muscular Atrophy (SMA)

      • 1.2.3 Type III Spinal Muscular Atrophy (SMA)

    • 1.3 Global Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Ambulatory Surgical Centers

      • 1.3.3 Diagnostic Centers

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Spinal Muscular Atrophy (SMA) Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Spinal Muscular Atrophy (SMA) Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Spinal Muscular Atrophy (SMA) Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Spinal Muscular Atrophy (SMA) Treatment Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Spinal Muscular Atrophy (SMA) Treatment Industry Porter's Five Forces Model Analysis

      • 2.2.3 Spinal Muscular Atrophy (SMA) Treatment Industry PEST Analysis

    • 2.3 Spinal Muscular Atrophy (SMA) Treatment Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Spinal Muscular Atrophy (SMA) Treatment Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Spinal Muscular Atrophy (SMA) Treatment Industry

    Chapter 3 Global and China Spinal Muscular Atrophy (SMA) Treatment Market, by Manufacturer

    • 3.1 Global and China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Spinal Muscular Atrophy (SMA) Treatment Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Spinal Muscular Atrophy (SMA) Treatment Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Spinal Muscular Atrophy (SMA) Treatment Market Top 3 Players

    Chapter 4 Global and China Spinal Muscular Atrophy (SMA) Treatment Market, by Type (2017-2028)

    • 4.1 Spinal Muscular Atrophy (SMA) Treatment Market Trend, by Type

    • 4.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Spinal Muscular Atrophy (SMA) Treatment Price Trend, by Type (2017-2028)

    • 4.3 China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Spinal Muscular Atrophy (SMA) Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Spinal Muscular Atrophy (SMA) Treatment Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Spinal Muscular Atrophy (SMA) Treatment Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Spinal Muscular Atrophy (SMA) Treatment Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Spinal Muscular Atrophy (SMA) Treatment Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Spinal Muscular Atrophy (SMA) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Spinal Muscular Atrophy (SMA) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Spinal Muscular Atrophy (SMA) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Spinal Muscular Atrophy (SMA) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Spinal Muscular Atrophy (SMA) Treatment Market Analysis

    • 7.1 North America Spinal Muscular Atrophy (SMA) Treatment Market, by Type

    • 7.2 North America Spinal Muscular Atrophy (SMA) Treatment Market, by Application

    • 7.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Analysis and Forecast, by Country

      • 7.3.1 United States Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Spinal Muscular Atrophy (SMA) Treatment Market Analysis

    • 8.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market, by Type

    • 8.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market, by Application

    • 8.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Analysis and Forecast, by Country

      • 8.3.1 Germany Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Spinal Muscular Atrophy (SMA) Treatment Market Analysis

    • 9.1 APAC Spinal Muscular Atrophy (SMA) Treatment Market, by Type

    • 9.2 APAC Spinal Muscular Atrophy (SMA) Treatment Market, by Application

    • 9.3 APAC Spinal Muscular Atrophy (SMA) Treatment Market Analysis and Forecast, by Country

      • 9.3.1 China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Analysis

    • 10.1 Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market, by Type

    • 10.2 Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market, by Application

    • 10.3 Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Spinal Muscular Atrophy (SMA) Treatment Company Profiles

      • 11.1 Biogen Idec

        • 11.1.1 Biogen Idec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product Profiles, Application and Specification

        • 11.1.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Ionis Pharmaceuticals

        • 11.2.1 Ionis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Ionis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Profiles, Application and Specification

        • 11.2.3 Ionis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Scholor Rock

        • 11.3.1 Scholor Rock Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Scholor Rock Spinal Muscular Atrophy (SMA) Treatment Product Profiles, Application and Specification

        • 11.3.3 Scholor Rock Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Novartis

        • 11.4.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Novartis Spinal Muscular Atrophy (SMA) Treatment Product Profiles, Application and Specification

        • 11.4.3 Novartis Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Roche

        • 11.5.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Roche Spinal Muscular Atrophy (SMA) Treatment Product Profiles, Application and Specification

        • 11.5.3 Roche Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Pfizer

        • 11.6.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Pfizer Spinal Muscular Atrophy (SMA) Treatment Product Profiles, Application and Specification

        • 11.6.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Isis Pharmaceuticals

        • 11.7.1 Isis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Profiles, Application and Specification

        • 11.7.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Spinal Muscular Atrophy (SMA) Treatment Industry Investment Prospect and Risk Assessment

    • 12.1 Spinal Muscular Atrophy (SMA) Treatment Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Spinal Muscular Atrophy (SMA) Treatment Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Production Value and Growth Rate (2017-2028)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Production Value and Growth Rate (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Type I Spinal Muscular Atrophy (SMA) (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Type II Spinal Muscular Atrophy (SMA) (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Type III Spinal Muscular Atrophy (SMA) (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Ambulatory Surgical Centers (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Diagnostic Centers (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Spinal Muscular Atrophy (SMA) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Spinal Muscular Atrophy (SMA) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Spinal Muscular Atrophy (SMA) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Spinal Muscular Atrophy (SMA) Treatment Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Spinal Muscular Atrophy (SMA) Treatment Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Spinal Muscular Atrophy (SMA) Treatment Market Share, by Manufacturer in 2021

    • Figure Global and China Spinal Muscular Atrophy (SMA) Treatment Market Share, by Manufacturer in 2022

    • Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Type (2017-2028)

    • Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Type (2017-2028)

    • Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Value, by Type (2017-2028)

    • Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Value Share, by Type (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Price Trend, by Type (2017-2028)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Type (2017-2028)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Type (2017-2028)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Sales Value, by Type (2017-2028)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Sales Value Share, by Type (2017-2028)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Price Trend, by Type (2017-2028)

    • Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Application (2017-2028)

    • Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Application (2017-2028)

    • Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Value, by Application (2017-2028)

    • Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Value Share, by Application (2017-2028)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Value Share, by Application (2017-2028)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Application (2017-2028)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Application (2017-2028)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Sales Value, by Application (2017-2028)

    • Table China Spinal Muscular Atrophy (SMA) Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure North America Spinal Muscular Atrophy (SMA) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Spinal Muscular Atrophy (SMA) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Spinal Muscular Atrophy (SMA) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Production, Import, Consumption and Export (2017-2022)

    • Table North America Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Type (2017-2028)

    • Table North America Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure North America Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Type (2017-2028)

    • Table North America Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Application (2017-2028)

    • Table North America Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure North America Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure United States Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure United States Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Canada Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Table Europe Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Type (2017-2028)

    • Table Europe Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Europe Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Type (2017-2028)

    • Table Europe Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Application (2017-2028)

    • Table Europe Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Europe Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Germany Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure UK Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure UK Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure France Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure France Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Italy Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Spain Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Poland Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Russia Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Table APAC Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Type (2017-2028)

    • Table APAC Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure APAC Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Type (2017-2028)

    • Table APAC Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Application (2017-2028)

    • Table APAC Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure APAC Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Japan Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure India Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure India Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Spinal Muscular Atrophy (SMA) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Spinal Muscular Atrophy (SMA) Treatment Sales Value and Growth Rate (2017-2028)

    • Table Biogen Idec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biogen Idec Product Profiles, Application and Specification

    • Table Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ionis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ionis Pharmaceuticals Product Profiles, Application and Specification

    • Table Ionis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Scholor Rock Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Scholor Rock Product Profiles, Application and Specification

    • Table Scholor Rock Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Isis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Isis Pharmaceuticals Product Profiles, Application and Specification

    • Table Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US